C3.ai (AI) 10-Q 2 Mar 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jan. 31, 2022	Feb. 28, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 31, 2022
Document Transition Report	false
Entity File Number	001-39744
Entity Registrant Name	C3.ai, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-3999357
Entity Address, Address Line One	1300 Seaport Blvd,
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	Redwood City,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94063
City Area Code	650
Local Phone Number	503-2200
Title of 12(b) Security	Class A Common Stock, par value $0.001 per share
Trading Symbol	AI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Current Fiscal Year End Date	--04-30
Amendment Flag	false
Entity Central Index Key	0001577526
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		102,871,811
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		3,499,992

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Jan. 31, 2022	Apr. 30, 2021
Current assets
Cash and cash equivalents		$ 204,531	$ 115,355
Short-term investments		764,104	978,020
Accounts receivable, net of allowance of $57 and $812 as of January 31, 2022 and April 30, 2021, respectively(1)	[1]	68,178	65,460
Prepaid expenses and other current assets	[2]	25,754	14,302
Total current assets		1,062,567	1,173,137
Property and equipment, net		5,297	6,133
Goodwill		625	625
Long-term investments		54,012	0
Other assets, non-current	[3]	65,006	16,582
Total assets		1,187,507	1,196,477
Current liabilities
Accounts payable	[4]	14,478	12,075
Accrued compensation and employee benefits		22,588	21,829
Deferred revenue, current	[5]	58,524	72,263
Accrued and other current liabilities	[6]	33,598	18,318
Total current liabilities		129,188	124,485
Deferred revenue, non-current		924	2,964
Other long-term liabilities	[7]	30,720	7,853
Total liabilities		160,832	135,302
Commitments and contingencies (note 6)
Stockholders’ equity
Additional paid-in capital		1,510,343	1,410,325
Accumulated other comprehensive (loss) income		(796)	81
Accumulated deficit		(482,978)	(349,333)
Total stockholders’ equity		1,026,675	1,061,175
Total liabilities and stockholders’ equity		1,187,507	1,196,477
Class A Common Stock
Stockholders’ equity
Common stock		103	99
Class B Common Stock
Stockholders’ equity
Common stock		$ 3	$ 3
[1]	Including amounts from a related party of $15,727 and $15,180 as of January 31, 2022 and April 30, 2021, respectively.
[2]	Including amounts from a related party of $5,010 and $1,662 as of January 31, 2022 and April 30, 2021, respectively.
[3]	Including amounts from a related party of $17,356 and $6,602 as of January 31, 2022 and April 30, 2021, respectively.
[4]	Including amounts from a related party of $2,415 and $56 as of January 31, 2022 and April 30, 2021, respectively.
[5]	Including amounts from a related party of $575 and $7,697 as of January 31, 2022 and April 30, 2021, respectively.
[6]	Including amounts from a related party of $18,534 and $3,413 as of January 31, 2022 and April 30, 2021, respectively.
[7]	Including amounts from a related party of $2,448 and $4,895 as of January 31, 2022 and April 30, 2021, respectively.

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands		Jan. 31, 2022	Apr. 30, 2021
Accounts receivable, allowance		$ 57	$ 812
Accounts receivable, net, from related party		15,727	15,180
Prepaid expenses and other current assets, from related party	[1]	25,754	14,302
Other assets, non-current, due from related party	[2]	65,006	16,582
Accounts payable, from related party		2,415	56
Deferred revenue, current, from related party	[3]	58,524	72,263
Accrued and other current liabilities, from related party	[4]	33,598	18,318
Other long-term liabilities, from related party		2,448	4,895
Related Party
Prepaid expenses and other current assets, from related party		5,010	1,662
Other assets, non-current, due from related party		17,356	6,602
Deferred revenue, current, from related party		575	7,697
Accrued and other current liabilities, from related party		$ 18,534	$ 3,413
Class A Common Stock
Common stock, par value (in dollars per share)		$ 0.001	$ 0.001
Common stock, shares authorized (in shares)		1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)		102,784,741	98,667,121
Common stock, shares outstanding (in shares)		102,784,741	98,667,121
Class B Common Stock
Common stock, par value (in dollars per share)		$ 0.001	$ 0.001
Common stock, shares authorized (in shares)		3,500,000	3,500,000
Common stock, shares issued (in shares)		3,499,992	3,499,992
Common stock, shares outstanding (in shares)		3,499,992	3,499,992
[1]	Including amounts from a related party of $5,010 and $1,662 as of January 31, 2022 and April 30, 2021, respectively.
[2]	Including amounts from a related party of $17,356 and $6,602 as of January 31, 2022 and April 30, 2021, respectively.
[3]	Including amounts from a related party of $575 and $7,697 as of January 31, 2022 and April 30, 2021, respectively.
[4]	Including amounts from a related party of $18,534 and $3,413 as of January 31, 2022 and April 30, 2021, respectively.

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2022	Jan. 31, 2021
Revenue
Total revenue		$ 69,773	$ 49,109	$ 180,442	$ 130,933
Cost of revenue
Total cost of revenue		17,354	12,226	46,350	32,807
Gross profit		52,419	36,883	134,092	98,126
Operating expenses
Sales and marketing	[1]	43,146	28,450	126,134	64,898
Research and development		40,931	18,748	104,166	48,145
General and administrative		15,748	8,184	43,391	21,433
Total operating expenses		99,825	55,382	273,691	134,476
Loss from operations		(47,406)	(18,499)	(139,599)	(36,350)
Interest income		410	129	1,077	997
Other income (expense), net		7,742	1,721	5,471	4,163
Net loss before provision for income taxes		(39,254)	(16,649)	(133,051)	(31,190)
Provision for income taxes		193	203	594	456
Net loss		$ (39,447)	$ (16,852)	$ (133,645)	$ (31,646)
Class A Common Stock
Operating expenses
Net loss per share attributable to common shareholders, basic (in dollars per share)		$ (0.38)	$ (0.23)	$ (1.29)	$ (0.64)
Net loss per share attributable to common shareholders, diluted (in dollars per share)		$ (0.38)	$ (0.23)	$ (1.29)	$ (0.64)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)		101,593,000	68,648,000	100,341,000	43,481,000
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)		101,593,000	68,648,000	100,341,000	43,481,000
Class A-1 Common Stock
Operating expenses
Net loss per share attributable to common shareholders, basic (in dollars per share)		$ 0	$ (0.10)	$ 0	$ (0.52)
Net loss per share attributable to common shareholders, diluted (in dollars per share)		$ 0	$ (0.10)	$ 0	$ (0.52)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)		0	6,667,000	0	6,667,000
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)		0	6,667,000	0	6,667,000
Class B Common Stock
Operating expenses
Net loss per share attributable to common shareholders, basic (in dollars per share)		$ (0.38)	$ (0.13)	$ (1.29)	$ (0.12)
Net loss per share attributable to common shareholders, diluted (in dollars per share)		$ (0.38)	$ (0.13)	$ (1.29)	$ (0.12)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)		3,500,000	3,500,000	3,500,000	3,500,000
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)		3,500,000	3,500,000	3,500,000	3,500,000
Subscription
Revenue
Total revenue	[2]	$ 57,084	$ 42,699	$ 150,614	$ 114,248
Cost of revenue
Total cost of revenue	[3]	12,275	7,023	32,880	22,694
Professional services
Revenue
Total revenue	[4]	12,689	6,410	29,828	16,685
Cost of revenue
Total cost of revenue		$ 5,079	$ 5,203	$ 13,470	$ 10,113
[1]	Including related party sales and marketing expense of $2,398 and nil for the three months ended January 31, 2022 and 2021, respectively, and $2,590 and nil for the nine months ended January 31, 2022 and 2021, respectively.
[2]	Including related party revenue of $19,740 and $7,951 for the three months ended January 31, 2022 and 2021, respectively, and $39,960 and $21,571 for the nine months ended January 31, 2022 and 2021, respectively.
[3]	Including related party cost of revenue of $191 and nil for the three months ended January 31, 2022 and 2021, respectively, and $388 and nil for the nine months ended January 31, 2022 and 2021, respectively.
[4]	Including related party revenue of $4,892 and nil for the three months ended January 31, 2022 and 2021, respectively, and $12,890 and nil for the nine months ended January 31, 2022 and 2021, respectively.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2022	Jan. 31, 2021
Related party cost of revenue		$ 17,354	$ 12,226	$ 46,350	$ 32,807
Related party sales and marketing	[1]	43,146	28,450	126,134	64,898
Investor
Related party sales and marketing		2,398	0	2,590	0
Subscription
Related party cost of revenue	[2]	12,275	7,023	32,880	22,694
Subscription | Investor
Related party revenue		19,740	7,951	39,960	21,571
Related party cost of revenue		191	0	388	0
Professional services
Related party cost of revenue		5,079	5,203	13,470	10,113
Professional services | Investor
Related party revenue		$ 4,892	$ 0	$ 12,890	$ 0
[1]	Including related party sales and marketing expense of $2,398 and nil for the three months ended January 31, 2022 and 2021, respectively, and $2,590 and nil for the nine months ended January 31, 2022 and 2021, respectively.
[2]	Including related party cost of revenue of $191 and nil for the three months ended January 31, 2022 and 2021, respectively, and $388 and nil for the nine months ended January 31, 2022 and 2021, respectively.

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2022	Jan. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (39,447)	$ (16,852)	$ (133,645)	$ (31,646)
Other comprehensive loss
Unrealized loss on available-for-sale marketable securities, net of tax	(556)	(49)	(877)	(411)
Total comprehensive loss	$ (40,003)	$ (16,901)	$ (134,522)	$ (32,057)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK, REDEEMABLE CONVERTIBLE CLASS A-1 COMMON STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Redeemable Convertible Preferred Stock	Redeemable Convertible A-1 Common Stock
Beginning Balance, shares (in shares) at Apr. 30, 2020						37,129,000	6,667,000
Beginning Balance, Amount at Apr. 30, 2020						$ 375,207	$ 18,800
Increase (Decrease) in Temporary Equity [Roll Forward]
Repayment of shareholder loan						$ 24,546
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)						(37,129,000)	(6,667,000)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering						$ (399,753)	$ (18,800)
Ending Balance, shares (in shares) at Jan. 31, 2021						0	0
Ending Balance, Amount at Jan. 31, 2021						$ 0	$ 0
Beginning Balance, shares (in shares) at Apr. 30, 2020		31,210,000
Beginning Balance, Amount at Apr. 30, 2020	$ (182,697)	$ 31	$ 110,485	$ 424	$ (293,637)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repayment of shareholder loan	1,457		1,457
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		43,796,000
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	418,553	$ 44	418,509
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts (in shares)		21,396,000
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts	844,646	$ 21	844,625
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)		4,530,000
Issuance of Class A common stock upon exercise of stock options, net of repurchases	7,867	$ 5	7,862
Vesting of early exercised Class A common stock options	2,073		2,073
Stock-based compensation expense	14,270		14,270
Other comprehensive loss	(411)			(411)
Net loss	(31,646)				(31,646)
Ending Balance, shares (in shares) at Jan. 31, 2021		100,932,000
Ending Balance, Amount at Jan. 31, 2021	1,074,112	$ 101	1,399,281	13	(325,283)
Beginning Balance, shares (in shares) at Oct. 31, 2020						37,129,000	6,667,000
Beginning Balance, Amount at Oct. 31, 2020						$ 399,753	$ 18,800
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)						(37,129,000)	(6,667,000)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering						$ (399,753)	$ (18,800)
Ending Balance, shares (in shares) at Jan. 31, 2021						0	0
Ending Balance, Amount at Jan. 31, 2021						$ 0	$ 0
Beginning Balance, shares (in shares) at Oct. 31, 2020		32,981,000
Beginning Balance, Amount at Oct. 31, 2020	(184,327)	$ 33	124,009	62	(308,431)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		43,796,000
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	418,553	$ 44	418,509
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts (in shares)		21,396,000
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts	844,646	$ 21	844,625
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)		2,759,000
Issuance of Class A common stock upon exercise of stock options, net of repurchases	4,803	$ 3	4,800
Vesting of early exercised Class A common stock options	749		749
Stock-based compensation expense	6,589		6,589
Other comprehensive loss	(49)			(49)
Net loss	(16,852)				(16,852)
Ending Balance, shares (in shares) at Jan. 31, 2021		100,932,000
Ending Balance, Amount at Jan. 31, 2021	1,074,112	$ 101	1,399,281	13	(325,283)
Beginning Balance, shares (in shares) at Apr. 30, 2021						0	0
Beginning Balance, Amount at Apr. 30, 2021						$ 0	$ 0
Ending Balance, shares (in shares) at Jan. 31, 2022						0	0
Ending Balance, Amount at Jan. 31, 2022						$ 0	$ 0
Beginning Balance, shares (in shares) at Apr. 30, 2021		102,167,000
Beginning Balance, Amount at Apr. 30, 2021	$ 1,061,175	$ 102	1,410,325	81	(349,333)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)	4,174,000	4,064,000
Issuance of Class A common stock upon exercise of stock options, net of repurchases	$ 19,818	$ 4	19,814
Vesting of early exercised Class A common stock options	2,391		2,391
Vesting of restricted stock units (in shares)		54,000
Stock-based compensation expense	77,813		77,813
Other comprehensive loss	(877)			(877)
Net loss	(133,645)				(133,645)
Ending Balance, shares (in shares) at Jan. 31, 2022		106,285,000
Ending Balance, Amount at Jan. 31, 2022	1,026,675	$ 106	1,510,343	(796)	(482,978)
Beginning Balance, shares (in shares) at Oct. 31, 2021						0	0
Beginning Balance, Amount at Oct. 31, 2021						$ 0	$ 0
Ending Balance, shares (in shares) at Jan. 31, 2022						0	0
Ending Balance, Amount at Jan. 31, 2022						$ 0	$ 0
Beginning Balance, shares (in shares) at Oct. 31, 2021		104,871,000
Beginning Balance, Amount at Oct. 31, 2021	1,026,510	$ 105	1,470,176	(240)	(443,531)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)		1,397,000
Issuance of Class A common stock upon exercise of stock options, net of repurchases	8,324	$ 1	8,323
Vesting of early exercised Class A common stock options	483		483
Vesting of restricted stock units (in shares)		17,000
Stock-based compensation expense	31,361		31,361
Other comprehensive loss	(556)			(556)
Net loss	(39,447)				(39,447)
Ending Balance, shares (in shares) at Jan. 31, 2022		106,285,000
Ending Balance, Amount at Jan. 31, 2022	$ 1,026,675	$ 106	$ 1,510,343	$ (796)	$ (482,978)

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		9 Months Ended
		Jan. 31, 2022	Jan. 31, 2021
Cash flows from operating activities:
Net loss		$ (133,645)	$ (31,646)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization		3,761	3,189
Non-cash operating lease cost		2,369	2,474
Stock-based compensation expense		77,813	14,270
Other		255	(115)
Changes in operating assets and liabilities
Accounts receivable	[1]	(1,963)	588
Prepaid expenses, other current assets and other assets	[2]	(21,108)	(6,931)
Accounts payable	[3]	2,237	7,447
Accrued compensation and employee benefits		759	4,303
Operating lease liabilities		(2,303)	(2,636)
Other liabilities	[4]	14,304	1,213
Deferred revenue	[5]	(15,779)	2,016
Net cash used in operating activities		(73,300)	(5,828)
Cash flows from investing activities:
Purchases of property and equipment		(2,183)	(1,166)
Capitalized software development costs		(500)	0
Proceeds from sale of non-marketable equity security		0	725
Purchases of investments		(540,290)	(232,287)
Maturities and sales of investments		698,312	280,997
Net cash provided by investing activities		155,339	48,269
Cash flows from financing activities:
Proceeds from initial public offering and private placements, net of underwriting discounts		0	851,859
Proceeds from repayment of shareholder loan		0	26,003
Payment of deferred offering costs		(105)	(6,710)
Proceeds from exercise of Class A common stock options		19,334	13,825
Net cash provided by financing activities		19,229	884,977
Net increase in cash, cash equivalents and restricted cash		101,268	927,418
Cash, cash equivalents and restricted cash at beginning of period		116,255	33,604
Cash and cash equivalents		204,531	960,122
Restricted cash included in other assets		12,992	900
Cash, cash equivalents and restricted cash at end of period		217,523	961,022
Total cash, cash equivalents and restricted cash		217,523	961,022
Supplemental disclosure of cash flow information—cash paid for income taxes		677	435
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued liabilities		483	349
Right-of-use assets obtained in exchange for lease obligations		26,529	0
Unpaid liabilities related to intangible purchases		2,500	0
Receivable from exercise of stock options included in prepaid expenses, other current assets and other assets		45	0
Deferred offering costs included in accounts payable and accrued liabilities		0	503
Vesting of early exercised stock options		$ 2,391	$ 2,073
[1]	Including changes in related party balances of $547 and $(780) for the nine months ended January 31, 2022 and 2021, respectively.
[2]	Including changes in related party balances of $14,102 and nil for the nine months ended January 31, 2022 and 2021, respectively.
[3]	Including changes in related party balances of $2,359 and nil for the nine months ended January 31, 2022 and 2021, respectively.
[4]	Including changes in related party balances of $12,674 and nil for the nine months ended January 31, 2022 and 2021, respectively.
[5]	Including changes in related party balances of $(7,122) and $7,859 for the nine months ended January 31, 2022 and 2021, respectively.

CONDENSED CONSOLIDATED STATEM_6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Thousands		9 Months Ended
		Jan. 31, 2022	Jan. 31, 2021
Related party balanced included in prepaid expenses, other current assets and other assets	[1]	$ 21,108	$ 6,931
Related party balances included in other liabilities	[2]	14,304	1,213
Investor
Related party balances included in accounts receivable		547	(780)
Related party balanced included in prepaid expenses, other current assets and other assets		14,102	0
Related party balances included in accounts payable		2,359	0
Related party balances included in other liabilities		12,674	0
Related party balance included in deferred revenue		$ (7,122)	$ 7,859
[1]	Including changes in related party balances of $14,102 and nil for the nine months ended January 31, 2022 and 2021, respectively.
[2]	Including changes in related party balances of $12,674 and nil for the nine months ended January 31, 2022 and 2021, respectively.

Summary of Business and Signifi

Summary of Business and Significant Accounting Policies	9 Months Ended
	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Business and Significant Accounting Policies	Summary of Business and Significant Accounting Policies Business C3.ai, Inc. (including its subsidiaries, “C3 AI” or “the Company”) is an enterprise artificial intelligence (“AI”) software provider. C3 AI supports accelerating digital transformation in various industries with its C3 AI Suite, its C3 AI Ex Machina, C3 AI CRM and C3 AI Data Vision solutions, and its prebuilt and configurable C3 AI Applications for a variety of business use cases including predictive maintenance, fraud detection, sensor network health, supply network optimization, energy management, anti-money laundering, and customer engagement. The Company supports customers in the United States, Europe, and the rest of the world. The Company was initially formed as a limited liability company in Delaware on January 8, 2009 and converted to a Delaware corporation in June 2012. Reclassification and Reverse Stock Split In November 2020, the Company amended and restated its certificate of incorporation to effect a reclassification of the Company’s prior Class B common stock and Class C common stock into Class A common stock, and redeemable convertible Class B-1 common stock into a new redeemable convertible Class A-1 common stock. The rights, including the liquidation, dividend, and voting rights, are substantially identical for each class of common stock reclassified. All references to prior Class B common stock and Class C common stock have been recast to Class A common stock, and all references to redeemable convertible Class B-1 common stock have been recast to redeemable convertible Class A-1 common stock in these condensed consolidated financial statements to give retrospective effect to the reclassification for all periods presented. The Company also authorized a new Class B common stock. The rights, including the liquidation and dividend rights, of the Class A common stock and the new Class B common stock are substantially identical, other than the voting rights and conversion rights upon transfer of the Class B common stock. See Note 8. Stockholders’ Equity for more information. Additionally, the Company effected a 6-for-1 reverse stock split of the Company’s outstanding common stock, preferred stock, and stock option awards. The par value of the common stock and preferred stock was not adjusted as a result of the reverse stock split. The authorized shares of the Class A common stock, new Class A-1 common stock, new Class B common stock and preferred stock were also adjusted to 390,000,000 shares, 6,666,667 shares, 21,000,000 shares, and 233,107,379 shares, respectively. All authorized, issued, and outstanding shares of common stock, preferred stock, stock option awards, and per share data included in these condensed consolidated financial statements have been recast to give retrospective effect to the adjusted authorized shares and reverse stock split for all periods presented. Initial Public Offering and Concurrent Private Placements In December 2020, the Company completed its initial public offering (“IPO”), in which the Company issued and sold 17,825,000 shares of its Class A common stock at $42.00 per share, which included 2,325,000 shares issued upon the exercise of the underwriters’ over-allotment option to purchase additional shares. The Company received net proceeds of $694.6 million after deducting underwriting discounts and other offering expenses. In connection with the IPO: • all 33,628,776 shares of the Company’s outstanding redeemable convertible preferred stock, except the Series A* preferred stock, automatically converted into an equivalent number of shares of Class A common stock on a one-to-one basis; • all 3,499,992 shares of the Company’s outstanding redeemable convertible Series A* preferred stock automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis; • all 6,666,665 shares of the Company’s outstanding redeemable convertible Class A-1 common stock automatically converted into an equivalent number of shares of Class A common stock on a one-to-one basis; and • the Company amended and restated its certificate of incorporation which became effective upon completion of the IPO. Deferred offering costs consist primarily of direct and incremental accounting, legal and other fees related to the Company’s IPO. Prior to the IPO, all deferred offering costs incurred were capitalized and included in other assets on the condensed consolidated balance sheet. Upon completion of the IPO, $7.2 million of deferred offering costs were reclassified into stockholders’ equity as a reduction of the IPO proceeds. The Company also completed a concurrent private placement immediately subsequent to the closing of the IPO, in which the Company issued and sold 2,380,952 and 1,190,476 shares, respectively, of its Class A common stock at $42.00 per share to Spring Creek Capital LLC, an affiliate of Koch Industries, Inc., and Microsoft Corporation (the “Concurrent Private Placement”). The Company received aggregate proceeds of $150.0 million and did not pay underwriting discounts with respect to the shares of Class A common stock that were sold in the Concurrent Private Placement. Basis of Presentation and Principles of Consolidation The Company prepares its unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2021, which was filed with the SEC on June 25, 2021. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of January 31, 2022, and the results of operations for the three and nine months ended January 31, 2022. The results of operations for the three and nine months ended January 31, 2022, are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements include the accounts of C3.ai, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers and estimating variable consideration, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Fiscal Year The Company’s fiscal year ends on April 30. Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 1. Summary of Business and Significant Accounting Policies in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the fiscal year ended April 30, 2021, which was filed with the SEC on June 25, 2021. There have been no significant changes to these policies during the three and nine months ended January 31, 2022. Recent Accounting Pronouncements The Company currently qualifies as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Accordingly, the Company is provided the option to adopt new or revised accounting guidance either (1) within the same periods as those otherwise applicable to public business entities or (2) within the same time periods as private companies, including early adoption when permissible. The Company has elected to adopt new or revised accounting guidance within the same time period as private companies. Based on the market value of the Company’s Class A common stock held by non-affiliates as of the last business day of the Company’s fiscal second quarter ended October 31, 2021, the Company will cease to be an emerging growth company as of April 30, 2022. Recently Adopted Accounting Standards In August 2018, the FASB issued ASU 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract , which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to defer and recognize as an asset. The guidance is effective for the fiscal year beginning May 1, 2021. Early adoption is permitted. The Company adopted this guidance effective May 1, 2021 on a prospective basis, and the adoption did not have a material impact on its condensed consolidated financial statements and related disclosures. In December 2019, the FASB issued ASU No. 2019-12, I ncome Taxes (Topic 740) —Simplifying the Accounting for Income Taxes. The amendments in this update simplify various aspects of the accounting for income tax by eliminating certain exceptions to the general approach under existing accounting guidance provided by ASC 740, Income Taxes, and clarifies certain aspects of the existing guidance to promote more consistent application. The amendments in this new standard include, the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill and that single-member limited liability companies and similar disregarded entities that are not subject to income tax are not required to recognize an allocation of consolidated income tax expense in their separate financial statements, but could elect to do so. The guidance is effective for the Company beginning May 1, 2022. Early adoption is permitted. The Company adopted this guidance effective May 1, 2021, and the adoption did not have a material impact on its condensed consolidated financial statements and related disclosures.

Revenue

Revenue	9 Months Ended
	Jan. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The following table presents revenue by geographical region (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2022 2021 2022 2021 North America (1) $ 56,846 $ 29,488 $ 136,995 $ 86,100 Europe, the Middle East and Africa (1) 11,108 17,141 36,116 39,922 Asia Pacific (1) 1,819 1,655 7,331 4,086 Rest of World (1) — 825 — 825 Total revenue $ 69,773 $ 49,109 $ 180,442 $ 130,933 __________________ (1) The United States comprised 81% and 60% of the Company’s revenue for the three months ended January 31, 2022 and 2021, respectively, and 76% and 65% of the Company’s revenue in the nine months ended January 31, 2022 and 2021, respectively. France comprised 8% and 12% of the Company’s revenue for the three months ended January 31, 2022 and 2021, respectively, and 11% and 12% of the Company’s revenue for the nine months ended January 31, 2022 and 2021, respectively. No other country comprised 10% or greater of the Company’s revenue for each of the three and nine months ended January 31, 2022 and 2021. Deferred Revenue The following table reflects the deferred revenue balance (in thousands): As of January 31, As of April 30, 2022 2021 Deferred revenue, current $ 58,524 $ 72,263 Deferred revenue, non-current 924 2,964 Total deferred revenue $ 59,448 $ 75,227 Significant changes in the deferred revenue balances during the nine months ended January 31, 2022 and 2021 were as follows (in thousands): Deferred Revenue April 30, 2021 $ 75,227 Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year (68,787) Increases due to invoicing prior to satisfaction of performance obligations 53,008 January 31, 2022 $ 59,448 Deferred Revenue April 30, 2020 $ 60,295 Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year (53,086) Increases due to invoicing prior to satisfaction of performance obligations 55,101 January 31, 2021 $ 62,310 Remaining Performance Obligation Remaining performance obligations are committed and represent non-cancellable contracted revenue that has not yet been recognized and will be recognized as revenue in future periods. Some contracts allow customers to cancel the contracts without a significant penalty, and the cancellable amount of contract value is not included in the remaining performance obligations. The Company excludes amounts related to performance obligations and usage-based royalties that are billed and recognized as they are delivered or billed and recognized in the same period. This primarily consists of monthly usage-based runtime and hosting charges in the duration of some revenue contracts. Revenue expected to be recognized from remaining performance obligations was approximately $469.3 million and $293.8 million as of January 31, 2022 and April 30, 2021, respectively, of which $171.6 million and $145.2 million is expected to be recognized over the next 12 months and the remainder thereafter, respectively. Customer Concentration and Accounts Receivable All of the Company’s Customer-Entities (as defined below) consist of corporate and governmental entities. A limited number of Customer-Entities have accounted for a large part of the Company’s revenue and accounts receivable to date. For the purpose of determining customer concentration and accounts receivable, unbilled receivables have been excluded from accounts receivable balance. Two separate Customer-Entities accounted for 36% and 10%, respectively, of revenue for the three months ended January 31, 2022. Two separate Customer-Entities accounted for 16% and 12%, respectively, of revenue for the three months ended January 31, 2021. Two separate Customer-Entities accounted for 30% and 10%, respectively, of revenue for the nine months ended January 31, 2022. Two separate Customer-Entities accounted for 16% and 12%, respectively, of revenue for the nine months ended January 31, 2021. Five separate Customer-Entities accounted for 21%, 19%, 14%, 12% and 10% of accounts receivable at January 31, 2022. Four separate Customer-Entities accounted for 18%, 14%, 14% and 11% of accounts receivable at April 30, 2021. A Customer-Entity is defined as each entity that is the ultimate parent of a party contracting with the Company. Accounts receivable includes billed and unbilled receivables, net of allowance of doubtful accounts. Trade accounts receivable are recorded at invoiced amounts and do not bear interest. The expectation of collectability is based on a review of credit profiles of customers, contractual terms and conditions, current economic trends, and historical payment experience. The Company regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice and the collection history of each customer to determine the appropriate amount of allowance for doubtful accounts. Accounts receivable included unbilled receivables as of January 31, 2022 and April 30, 2021 of $5.1 million and $3.8 million, respectively.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Jan. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company’s financial instruments consist primarily of cash equivalents, restricted cash, available-for-sale marketable securities, accounts receivable, and accounts payable. Cash and cash equivalents and available-for-sale marketable securities are reported at their respective fair values on the condensed consolidated balance sheets. The remaining financial instruments are reported on the condensed consolidated balance sheets at amounts that approximate current fair values. The following table summarizes the types of assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands): As of January 31, 2022 As of April 30, 2021 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 129,753 $ — $ — $ 129,753 $ 43,401 $ — $ — $ 43,401 Commercial paper — 10,998 — 10,998 — — — — Corporate debt securities — 1,506 — 1,506 — — — — Available-for-sale marketable securities: U.S. treasury securities — — — — — 57,998 — 57,998 Certificates of deposit — 300,381 — 300,381 — 422,978 — 422,978 U.S. government agencies securities — 14,015 — 14,015 — — — — Commercial paper — 308,208 — 308,208 — 494,676 — 494,676 Corporate debt securities — 195,512 — 195,512 — 2,368 — 2,368 Total cash equivalents and available-for-sale marketable securities $ 129,753 $ 830,620 $ — $ 960,373 $ 43,401 $ 978,020 $ — $ 1,021,421

Investments

Investments	9 Months Ended
	Jan. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Cash Equivalents and Available-for-Sale Marketable Securities The following table summarizes the Company’s cash equivalents and available-for-sale marketable securities (in thousands): As of January 31, 2022 As of April 30, 2021 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash equivalents: Money market funds $ 129,753 $ — $ — $ 129,753 $ 43,401 $ — $ — $ 43,401 Commercial paper 10,998 — — 10,998 — — — — Corporate debt securities 1,506 — — 1,506 — — — — Available-for-sale marketable securities: U.S. treasury securities — — — — 57,993 5 — 57,998 Certificates of deposit 300,377 4 — 300,381 422,952 32 (6) 422,978 U.S. government agencies securities 14,120 — (105) 14,015 — — — — Commercial paper 308,205 3 — 308,208 494,625 64 (13) 494,676 Corporate debt securities 196,210 — (698) 195,512 2,369 — (1) 2,368 Total cash equivalents and available-for-sale marketable securities $ 961,169 $ 7 $ (803) $ 960,373 $ 1,021,340 $ 101 $ (20) $ 1,021,421 The following table summarizes the Company’s available-for-sale marketable securities by contractual maturity (in thousands): As of January 31, 2022 As of April 30, 2021 Amortized Cost Fair Value Amortized Cost Fair Value Within one year $ 764,589 $ 764,104 $ 977,939 $ 978,020 After one year through five years 54,323 54,012 — — Total $ 818,912 $ 818,116 $ 977,939 $ 978,020 The following table summarizes the fair values and unrealized losses of the Company’s available-for-sale marketable securities classified by length of time that the securities have been in a continuous unrealized loss position but were not deemed to be other-than-temporarily impaired, as of January 31, 2022 (in thousands): As of January 31, 2022 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Certificates of deposit $ — $ 12,500 $ — $ — $ — $ 12,500 U.S. government agencies securities — — (105) 14,015 (105) 14,015 Commercial paper — 14,493 — — — 14,493 Corporate debt securities (490) 154,515 (208) 38,297 (698) 192,812 Total $ (490) $ 181,508 $ (313) $ 52,312 $ (803) $ 233,820

Balance Sheet Details

Balance Sheet Details	9 Months Ended
	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Details	Balance Sheet Details Property and Equipment Property and equipment consisted of the following at January 31, 2022 and April 30, 2021 (in thousands): Useful Life As of January 31, As of April 30, (in months) 2022 2021 Leasehold improvements * $ 8,895 $ 8,658 Computer equipment 36 3,860 2,539 Office furniture and equipment 60 348 339 Capital in progress NA 873 — Property and equipment—gross 13,976 11,536 Less: accumulated depreciation and amortization (8,679) (5,403) Property and equipment—net $ 5,297 $ 6,133 __________________ * Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. NA = Not Applicable Depreciation and amortization expense related to property and equipment was $1.1 million and $1.0 million for the three months ended January 31, 2022 and 2021, respectively, and $3.3 million and $3.0 million for the nine months ended January 31, 2022 and 2021, respectively. Accrued Compensation and Employee Benefits Accrued compensation and employee benefits consisted of the following at January 31, 2022 and April 30, 2021 (in thousands): As of January 31, As of April 30, 2022 2021 Accrued bonus $ 12,768 $ 12,216 Accrued vacation 3,479 3,935 Accrued payroll taxes and benefits 3,119 3,405 Accrued commission 808 1,863 Accrued salaries 2,414 410 Accrued compensation and employee benefits $ 22,588 $ 21,829 Accrued and Other Current Liabilities Accrued and other current liabilities consisted of the following at January 31, 2022 and April 30, 2021 (in thousands): As of January 31, As of April 30, 2022 2021 Liability for common stock exercised prior to vesting $ 2,449 $ 5,331 Accrued general expenses 5,154 3,588 Operating lease liabilities, current 3,246 3,894 Commissions payable to a related party 18,534 3,413 Other 4,215 2,092 Accrued and other current liabilities $ 33,598 $ 18,318 Cares Act Loan On May 1, 2020, the Company entered into a Paycheck Protection Program (“PPP”) Promissory Note and Agreement with Bank of America, pursuant to which the Company received loan proceeds of $6.3 million (the “PPP Loan”). The PPP Loan was made under, and was subject to the terms and conditions of, the PPP which was established under the CARES Act and is administered by the U.S. Small Business Administration. The term of the PPP Loan was two years with a maturity date of May 1, 2022 and contains a favorable fixed annual interest rate of 1.00%. Payments of principal and interest on the PPP Loan were deferred for the first six months of the term of the PPP Loan until November 1, 2020. Principal and interest were payable monthly and could be prepaid by the Company at any time prior to maturity with no prepayment penalties. On August 18, 2020, the Company repaid in full the PPP loan outstanding, including accrued interest of $0.1 million, in the amount of $6.4 million.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Jan. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Noncancelable Purchase Commitments The Company entered into a noncancelable arrangement with a web-hosting services provider in November 2019. Under the arrangement, the Company committed to spend an aggregate of at least $30.0 million between November 2019 and November 2022, with a minimum amount of $10.0 million in each of the three years, on services with this vendor. The Company has incurred costs totaling $3.8 million and $3.5 million during the three months ended January 31, 2022 and 2021, respectively, and $10.4 million and $9.6 million during the nine months ended January 31, 2022 and 2021, respectively, under the arrangement. C3.ai Digital Transformation Institute Grants In February 2020, the Company entered into an agreement establishing the C3.ai Digital Transformation Institute (“C3.ai DTI”), a program established to attract many of the world’s leading research institutions to join in a coordinated and innovative effort to advance the digital transformation of business, government, and society. As part of the agreement, the Company has agreed to issue grants to C3.ai DTI, which are subject to compliance with certain obligations. The grants shall be paid by the Company over five years in the form of cash, publicly traded securities, or other property of equivalent net value. As of January 31, 2022 and April 30, 2021, the total potential remaining contributions are $34.5 million and $43.1 million, respectively. The future grant payments are conditional in nature and subject to execution of the program in line with specific requirements. Leases On August 25, 2021, the Company entered into a new lease to acquire approximately 283,015 square feet of office space in several phases in Redwood City, California. Total undiscounted base rent payments over the term of this lease are approximately $103.1 million. In addition to base rent, the Company will be responsible for the Company’s allocated share of costs incurred and expenditures made by the landlord in the operation and management of the leased space. Under the terms of the lease agreement, the Company has a rent abatement with respect to each phase for the initial six months following the rent commencement date for such phase, with initial monthly base rent payments expected to commence April 1, 2023, which will be approximately $0.5 million at commencement and will increase up to a maximum monthly base rent of approximately $1.0 million. The lease agreement also includes an aggregate tenant improvement allowance of $44.2 million for certain costs. The term of the lease is 126 months from the date that rent commences with respect to phase one of the leased space, which will be nine months after the date when phase one of the leased space is delivered to the Company. Pursuant to the lease agreement, the Company provided the landlord an unconditional and irrevocable letter of credit of $12.6 million, which is subject to reduction pursuant to the terms of the lease agreement. The lease commencement date of the first two phases was determined to have occurred in the quarter ended January 31, 2022, when the landlord delivered the leased space to the Company. The Company recorded $26.5 million of lease liability in other long-term liabilities and corresponding right-of-use asset in other assets, non-current in the condensed consolidated balance sheets. Legal Proceedings The Company is involved in various legal proceedings and periodically receives claims arising in the ordinary course of business. In the Company’s opinion, resolution of these matters is not expected to have a material adverse impact on its condensed consolidated statement of operations, cash flows, or balance sheet. Blattman et al. v. Siebel et al., 15-cv-00530 (D. Del.) On October 28, 2014, Eric Blattman and other former unitholders of E2.0 LLC (“E2.0”), and collectively, the Plaintiffs, filed suit in federal court against Thomas M. Siebel and David Schmaier, alleging violation of Section 10(b) of the Securities Exchange Act of 1934 and common law fraud based on alleged misrepresentations made during negotiations leading up to an April 30, 2012 merger between E2.0 and the Company. Plaintiffs thereafter amended their complaint to add the Company as a defendant, and to add breach of contract claims based on alleged violations of certain earn-out and indemnification provisions in the parties’ merger agreement. A bench trial was held in February 2019, and in a January 29, 2020 opinion the court ruled in favor of defendants the Company, Siebel and Schmaier on all claims. The court also awarded defendants their reasonable attorneys’ fees and costs in defending the action. In February 2020, Plaintiffs appealed only the portion of the district court’s ruling related to the alleged breach of contract indemnification claim to the Third Circuit Court of Appeals. On February 17, 2021, the Third Circuit affirmed the judgment and orders of the district court in the Company’s and defendants’ favor. On August 10, 2021, the special master appointed by the district court to consider an order on recovery of fees and costs issued a recommendation that the Company be awarded $9.7 million in fees and expenses. Plaintiffs objected to the special master’s recommendation and requested an award of $8.3 million, which the Company opposed. On December 6, 2021, the district court issued an order awarding $9.4 million in attorney’s fees and costs to the Company. The Company received the award in January 2022 and recorded $9.4 million in other income (expenses), in the condensed consolidated statement of operations for the three and nine months ended January 31, 2022.

Redeemable Convertible Preferre

Redeemable Convertible Preferred Stock and Redeemable Convertible A-1 Common Stock	9 Months Ended
	Jan. 31, 2022
Temporary Equity Disclosure [Abstract]
Redeemable Convertible Preferred Stock and Redeemable Convertible A-1 Common Stock	Redeemable Convertible Preferred Stock and Redeemable Convertible A-1 Common Stock Upon completion of the IPO, all 33,628,776 shares of the Company’s outstanding redeemable convertible preferred stock, except the Series A* preferred stock, automatically converted into an equivalent number of shares of Class A common stock on a one-to-one basis and all 3,499,992 shares of the Company’s outstanding redeemable convertible Series A* preferred stock automatically converted into an equivalent number of shares of the Company’s Class B common stock on a one-to-one basis. The carrying value of $399.8 million of all classes of the Company’s outstanding redeemable convertible preferred stock was reclassified into stockholders’ equity. Additionally, all 6,666,665 shares of the Company’s outstanding redeemable convertible Class A-1 common stock automatically converted into an equivalent number of shares of Class A common stock on a one-to-one basis and their carrying value of $18.8 million was reclassified into stockholders’ equity. As of January 31, 2022, there were no shares of redeemable convertible preferred stock issued and outstanding. See Note 1. Summary of Business and Significant Accounting Policies for more information.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Jan. 31, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Preferred Stock The Company has authorized the issuance of 200,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of January 31, 2022, there were no shares of Preferred Stock issued or outstanding. Common Stock The Company has authorized the issuance of 1,000,000,000 shares of Class A common stock and 3,500,000 shares of Class B common stock. The shares of Class A common stock and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. Each share of Class A common stock is entitled to one vote. Each share of Class B common stock is entitled to 50 votes. Class A and Class B common stock have a par value of $0.001 per share and are referred to as common stock throughout the notes to the unaudited condensed consolidated financial statements, unless otherwise noted. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Shares of Class B common stock may be converted to Class A common stock at any time at the option of the stockholder. Each share of Class B common stock will be automatically converted into one share of Class A common stock upon the earliest of the following: (i) the date that is six months following the death or incapacity of Mr. Siebel; (ii) the date that is six months following the date that Mr. Siebel is no longer providing services to the Company as an officer, employee, director, or consultant; (iii) December 11, 2040, which is the twentieth anniversary of the completion of the IPO; or (iv) the date specified by the holders of a majority of the then outstanding shares of Class B common stock, voting as a separate class. Future transfers by holders of Class B common stock will generally result in those shares converting to Class A common stock. Common Stock Subject to Repurchase Under the Company’s Amended and Restated 2012 Equity Incentive Plan (the “2012 Incentive Plan”) and the Company’s Amended and Restated 2020 Equity Incentive Plan (the “2020 Incentive Plan”), certain optionholders are allowed to exercise stock options to purchase Class A common stock prior to vesting. The Company has the right to repurchase at the original purchase price any unvested but outstanding common shares upon termination of service of the optionholder. The consideration received for an early exercise of a stock option is considered to be a deposit of the exercise price and the related amount is recorded as a liability. The net proceeds from the early exercise of such options were nil and $4.5 million during the three months ended January 31, 2022 and 2021, respectively, and nil and $6.0 million during the nine months ended January 31, 2022 and 2021, respectively. The liability is reclassified into equity on a ratable basis as the stock options vest. Unvested Class A common stock of 479,327 and 1,091,306 shares as of January 31, 2022 and April 30, 2021, respectively, were subject to such repurchase right and are legally issued and outstanding as of each period presented. See Note 9. Stock-Based Compensation for more information. Stock Repurchase Program In December 2021, the Company's board of directors approved a stock repurchase program for the repurchase of up to $100.0 million of the Company’s outstanding shares of Class A common stock for the 18 months following the date of such approval. Under the program, the Company may purchase stock in the open market or through privately negotiated transactions in accordance with applicable securities laws. The timing and actual amount of the stock repurchases will depend on several factors including price, capital availability, regulatory requirements, alternative investment opportunities and other market conditions. During the three and nine months ended January 31, 2022, the Company has not repurchased any shares of its Class A common stock.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Jan. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation On June 29, 2012, the Company adopted the 2012 Incentive Plan. The 2012 Incentive Plan provided for the grant of stock-based awards to employees, non-employee directors, and other service providers of the Company. The 2012 Incentive Plan was terminated in December 2020 in connection with the IPO but continues to govern the terms of outstanding awards that were granted prior to the termination of the 2012 Incentive Plan. No further equity awards will be granted under the 2012 Incentive Plan. With the establishment of the 2020 Incentive Plan as further discussed below, upon the expiration, forfeiture, cancellation, or reacquisition of any shares of Class A common stock underlying outstanding stock-based awards granted under the 2012 Incentive Plan, an equal number of shares of Class A common stock will become available for grant under the 2020 Plan. On November 27, 2020, the Company’s board of directors adopted, and its stockholders approved, the 2020 Incentive Plan, which became effective in connection with the IPO. The 2020 Incentive Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit (“RSU”) awards, performance awards and other equity awards. The number of shares of Class A common stock reserved for issuance under the 2020 Incentive Plan is subject to automatic evergreen increases annually through (and including) May 1, 2030 pursuant to the terms of the 2020 Incentive Plan. There was an automatic annual increase on May 1, 2021 in the number of shares reserved for future issuance pursuant to the 2020 Incentive Plan in an amount equal to five percent (5%) of the total number of shares of the Company’s Class A common stock and Class B common stock outstanding on April 30, 2021. On November 27, 2020, the Company’s board of directors also adopted, and its stockholders also approved, the 2020 Employee Stock Purchase Plan (the “2020 ESPP”), which became effective immediately prior to the IPO. The 2020 ESPP authorizes the issuance of shares of Class A common stock pursuant to purchase rights granted to employees. A total of 3,000,000 shares of Class A common stock were initially reserved for future issuance under the 2020 ESPP. The number of shares of Class A common stock reserved for issuance under the 2020 ESPP is subject to automatic evergreen increases annually through (and including) May 1, 2030 pursuant to the terms of the 2020 ESPP. There was an automatic annual increase on May 1, 2021 in the number of shares reserved for future issuance pursuant to the 2020 ESPP in an amount equal to one percent (1%) of the total number of shares of the Company’s Class A common stock and Class B common stock outstanding on April 30, 2021. The 2020 ESPP permits participants to purchase shares of Class A common stock in an amount not exceeding 15% of their earnings during the relevant offering period. The offering dates and purchase dates for the 2020 ESPP are determined at the discretion of the Company’s board of directors. As of January 31, 2022, the Company had not yet launched its 2020 ESPP. Stock Options to Acquire Class A Common Stock These stock options generally expire 10 years from the date of grant, or earlier if services are terminated. Generally, each stock option for common stock is subject to a vesting schedule such that one fifth of the award vests after the first-year anniversary and one-sixtieth of the award vests each month thereafter over the remaining four years, subject to continuous service. A summary of the Company’s option activity during the nine months ended January 31, 2022 is as follows: Options Outstanding Number of Weighted Weighted Aggregate (in thousands) (in thousands) Balance as of April 30, 2021 38,487 $ 6.39 7.98 $ 2,304,714 Options granted 6,127 46.23 Options exercised (4,174) 4.76 Options cancelled (3,290) 13.71 Balance as of January 31, 2022 37,150 $ 12.47 7.59 $ 515,266 Vested and exercisable as of January 31, 2022 15,195 $ 5.10 6.50 $ 322,749 Vested and expected to vest as of January 31, 2022 (1) 37,629 $ 12.47 7.59 $ 521,914 (1) The number of options vested and expected to vest as of January 31, 2022 includes early exercised, unvested Class A common stock. Refer to Note 8. Stockholders’ Equit y for more information. As of January 31, 2022, there was $166.3 million of unrecognized compensation cost related to stock options which are expected to be recognized over an estimated weighted-average period of 3.4 years. The grant-date fair value of the options issued for the nine months ended January 31, 2022 is estimated on the date of grant using the Black-Scholes-Merton option pricing model. The weighted average assumptions underlying the fair value estimation are provided in the following table: As of January 31, 2022 2021 Valuation assumptions: Expected dividend yield — % — % Expected volatility 43.5 % 43.8 % Expected term (years) 6.5 6.3 Risk-free interest rate 1.4 % 0.4 % Restricted Stock Units During the fourth quarter of the fiscal year ended April 30, 2021, the Company began granting RSUs to its employees. No RSUs were granted prior to the IPO. The RSUs are typically subject to service-based vesting conditions satisfied over five years with one-fifth of the award vesting after the first-year anniversary and one-twenty-fifth of the award vesting quarterly thereafter. The related stock-based compensation is recognized on a straight-line basis over the requisite service period. A summary of the Company’s RSU activity during the nine months ended January 31, 2022 is as follows: RSUs Outstanding Number of RSUs Weighted Average (in thousands) Unvested Balance as of April 30, 2021 447 $ 74.52 RSUs granted 7,829 49.60 RSUs vested (54) 66.24 RSUs forfeited (1,297) 58.77 Unvested Balance as of January 31, 2022 6,925 $ 49.36 As of January 31, 2022, there was $296.2 million of unrecognized stock-based compensation expense related to outstanding RSUs granted to employees that is expected to be recognized over a weighted-average period of 3.9 years. Stock-based Compensation Expense The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2022 2021 2022 2021 Cost of subscription $ 2,639 $ 214 $ 5,824 $ 557 Cost of professional services 704 164 1,991 301 Sales and marketing 8,850 2,790 28,540 5,835 Research and development 12,846 846 25,860 1,952 General and administrative 6,322 2,575 15,598 5,625 Total stock-based compensation expense $ 31,361 $ 6,589 $ 77,813 $ 14,270 Shareholder Loan In January 2018, in connection with the Series F preferred stock financing, the Company issued 1,251,921 shares of Series F preferred stock in exchange for a note receivable of $24.5 million from its chief executive officer (“CEO”). Prior to the automatic conversion of all Series F preferred stock outstanding into Class A common stock upon the completion of the IPO, the underlying shares of Series F preferred stock were legally outstanding though were not included in the carrying amounts of preferred stock as the note receivable is treated as an equity classified stock-based option grant. In September 2020, the Company’s CEO paid the outstanding full recourse promissory note and accrued interest in the amount of $26.0 million. No interest income was recorded for the note. Refer to Note 12. Related Party Transactions for more information.

Income Taxes

Income Taxes	9 Months Ended
	Jan. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Accounting for income taxes for interim periods generally requires the provision for income taxes to be determined by applying an estimate of the annual effective tax rate for the full fiscal year to income or loss before income taxes, adjusted for discrete items, if any, for the reporting period. The Company updates its estimate of the annual effective tax rate each quarter and makes a cumulative adjustment in such period. The Company recorded income tax expense of $0.2 million and $0.2 million for the three months ended January 31, 2022 and 2021, respectively, and $0.6 million and $0.5 million for the nine months ended January 31, 2022 and 2021, respectively. Income tax expense consists primarily of income taxes in foreign jurisdictions in which the Company conducts business. Due to the Company’s history of losses in the United States, a full valuation allowance on substantially all of the Company’s deferred tax assets, including net operating loss carryforwards, research and development tax credits, and other book versus tax differences, was maintained.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
	Jan. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Class A and B common shares have identical liquidation and distribution rights. Prior to the automatic conversion of all shares of redeemable convertible Class A-1 common stock into Class A common stock upon the completion of the IPO, the shares of redeemable convertible Class A-1 common stock had a liquidation preference, but were legal form common stock and participated in losses equally with all common stockholders. Prior to the automatic conversion of all of its redeemable convertible preferred stock outstanding into Class A and Class B common stock upon the completion of the IPO, the Company considered all redeemable convertible preferred stock to be participating securities because they participated in any dividends declared on the Company’s common stock on an as-if-converted basis. Redeemable convertible preferred stock did not participate in the net loss per share with common stockholders as the holders of the convertible preferred did not have a contractual obligation to share in the Company’s losses. Accordingly, under the two-class method, the net loss is not allocated to the redeemable convertible preferred stock such that the resulting net loss for all periods presented was allocated on a proportionate basis to shares of Class A, Class A-1, and Class B common stock for the number of days that each class was issued and outstanding during the period. Basic net loss per share attributable to common stockholders is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net loss per share attributable to common stockholders is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period to the extent they are dilutive. For purposes of this calculation, the convertible preferred, stock options, and early exercised stock options subject to repurchase are considered to be potential common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive. Basic net loss per share was the same as diluted net loss per share for the periods presented because the Company was in a loss position for the three and nine months ended January 31, 2022 and 2021. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended January 31, Nine Months Ended January 31, 2022 2021 2022 2021 Numerator Net loss attributable to common stockholders $ (39,447) $ (16,852) $ (133,645) $ (31,646) Denominator Basic and diluted weighted-average Class A common shares outstanding 101,593 68,648 100,341 43,481 Basic and diluted weighted-average Class A-1 common shares outstanding — 6,667 — 6,667 Basic and diluted weighted-average Class B common shares outstanding 3,500 3,500 3,500 3,500 Basic and diluted net loss per share attributable to common stockholders Basic and diluted net loss per Class A common shares outstanding $ (0.38) $ (0.23) $ (1.29) $ (0.64) Basic and diluted net loss per Class A-1 common shares outstanding $ — $ (0.10) $ — $ (0.52) Basic and diluted net loss per Class B common shares outstanding $ (0.38) $ (0.13) $ (1.29) $ (0.12) The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have had an antidilutive effect were as follows: As of January 31, 2022 2021 Stock options 37,628,988 41,286,541 RSUs 6,925,310 —

Related Party Transactions

Related Party Transactions	9 Months Ended
	Jan. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Shareholder Loan In January 2018, the Company issued 1,251,921 shares of Series F Preferred Stock in exchange for a non-recourse promissory note to Thomas M. Siebel, the Company’s CEO, in the amount of $24.5 million. The promissory note has a term of five years with the ability to renew for up to four successive one year periods and bears interest at a rate of 2.18% per annum, compounded annually. In September 2020, Mr. Siebel paid the outstanding promissory note in full including accrued interest in the total amount of $26.0 million. Refer to Note 9. Stock-Based Compensation for more information. Revenue Transactions with Baker Hughes Company In June 2019, the Company entered into multiple agreements with Baker Hughes Company (“Baker Hughes”) under which Baker Hughes received a three-year subscription to use the Company’s software. These agreements were revised in June 2020 to extend the term to five years and modify the subscription fees due. Under the agreements as revised in June 2020, Baker Hughes made minimum, non-cancelable revenue commitments, inclusive of their direct subscription fees and third-party revenue generated through a joint marketing arrangement with Baker Hughes, in the amount of $46.7 million in fiscal year 2020, $53.3 million in fiscal year 2021, $75.0 million in fiscal year 2022, $125.0 million in fiscal year 2023, and $150.0 million in fiscal year 2024. The Company also agreed to pay Baker Hughes a sales commission on subscriptions and services offerings it resold in excess of these minimum revenue commitments. The Company and Baker Hughes further revised these agreements in October 2021 to extend the term by an additional year, for a total of six years, with an expiration date in the fiscal year ending April 30, 2025, to modify the amount of Baker Hughes’ annual commitments to $85.0 million in fiscal year 2023, $110.0 million in fiscal year 2024, and $125.0 million in fiscal year 2025, and to revise the structure of the arrangement to further incentivize Baker Hughes’ sales of the Company’s products and services. Beginning in fiscal year 2023, Baker Hughes’ annual commitments will be reduced by any revenue the Company generates from certain customers. The revenue recorded for Baker Hughes will be reviewed quarterly and adjusted, as needed, to reflect the Company’s current assumptions. Pursuant to the revised arrangement, the Company acknowledged that Baker Hughes had met its minimum annual revenue commitment for the current fiscal year and recognized $16.0 million of sales commission as deferred costs during the fiscal quarter ended October 31, 2021 related to this arrangement, which will be amortized over an expected period of five years. During the nine months ended January 31, 2022, the Company recognized total revenue of $70.9 million related to its arrangement with Baker Hughes. The remaining performance obligations related to Baker Hughes, which includes both direct subscriptions and reseller arrangements, is comprised of $2.3 million related to deferred revenue and $234.9 million of commitments from non-cancellable contracts as of January 31, 2022 and $8.5 million related to deferred revenue and $95.5 million from non-cancellable contracts as of April 30, 2021. The Company recognized subscription revenue from direct subscription fees from Baker Hughes of $19.7 million and $8.0 million during the three months ended January 31, 2022 and 2021, respectively, and $40.0 million and $21.6 million during the nine months ended January 31, 2022 and 2021, respectively. The Company recognized professional services revenue from Baker Hughes of $4.9 million and nil during the three months ended January 31, 2022 and 2021, respectively, and $12.9 million and nil during the nine months ended January 31, 2022 and 2021, respectively. As of January 31, 2022 and April 30, 2021, accounts receivable, net (inclusive of unbilled receivables) included $15.7 million and $15.2 million and deferred revenue, current included $0.6 million and $7.7 million, respectively. The Company recognized cost of subscription revenue related to services purchased from Baker Hughes of $0.2 million and nil during the three months ended January 31, 2022 and 2021, respectively, and $0.4 million and nil during the nine months ended January 31, 2022 and 2021, respectively. The Company recognized sales and marketing expenses related to Baker Hughes of $2.4 million and nil during the three months ended January 31, 2022 and 2021, respectively, and $2.6 million and nil during the nine months ended January 31, 2022 and 2021, respectively. As of January 31, 2022 and April 30, 2021, accounts payable included $2.4 million and $0.1 million, respectively. As of January 31, 2022 and April 30, 2021, the current portion of deferred costs of $5.0 million and $1.7 million, respectively, were included in prepaid expenses and other current assets and the non-current portion of $17.4 million and $6.6 million, respectively, were included in other assets, non-current. The Company amortized $1.2 million and $2.0 million of deferred commissions during the three and nine months ended January 31, 2022, and this amount was included in sales and marketing expense in the condensed consolidated statements of operations. The Company recognized $8.3 million and $16.0 million of sales commission as deferred costs during the fiscal year ended April 30, 2021 and the fiscal quarter ended January 31, 2022, respectively, related to this arrangement. The sales commissions of $8.3 million recognized in the fiscal year ended April 30, 2021 is payable to Baker Hughes over the term of three years based on the agreements, of which the Company paid $3.4 million during the nine months ended January 31, 2022. The sales commissions of $16.0 million recognized in the fiscal quarter ended January 31, 2022 will be amortized over an expected period of five years. As of January 31, 2022 and April 30, 2021, accrued and other current liabilities included $18.5 million and $3.4 million, respectively, and other long-term liabilities included $2.4 million and $4.9 million, respectively.

Summary of Business and Signi_2

Summary of Business and Significant Accounting Policies (Policies)	9 Months Ended
	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation and Principles of Consolidation The Company prepares its unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2021, which was filed with the SEC on June 25, 2021. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of January 31, 2022, and the results of operations for the three and nine months ended January 31, 2022. The results of operations for the three and nine months ended January 31, 2022, are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period.
Principles of Consolidation	The condensed consolidated financial statements include the accounts of C3.ai, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers and estimating variable consideration, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Fiscal Year	Fiscal YearThe Company’s fiscal year ends on April 30.
Recent Accounting Pronouncements and Recently Adopted Accounting Standards	Recent Accounting Pronouncements The Company currently qualifies as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Accordingly, the Company is provided the option to adopt new or revised accounting guidance either (1) within the same periods as those otherwise applicable to public business entities or (2) within the same time periods as private companies, including early adoption when permissible. The Company has elected to adopt new or revised accounting guidance within the same time period as private companies. Based on the market value of the Company’s Class A common stock held by non-affiliates as of the last business day of the Company’s fiscal second quarter ended October 31, 2021, the Company will cease to be an emerging growth company as of April 30, 2022. Recently Adopted Accounting Standards In August 2018, the FASB issued ASU 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract , which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to defer and recognize as an asset. The guidance is effective for the fiscal year beginning May 1, 2021. Early adoption is permitted. The Company adopted this guidance effective May 1, 2021 on a prospective basis, and the adoption did not have a material impact on its condensed consolidated financial statements and related disclosures. In December 2019, the FASB issued ASU No. 2019-12, I ncome Taxes (Topic 740) —Simplifying the Accounting for Income Taxes. The amendments in this update simplify various aspects of the accounting for income tax by eliminating certain exceptions to the general approach under existing accounting guidance provided by ASC 740, Income Taxes, and clarifies certain aspects of the existing guidance to promote more consistent application. The amendments in this new standard include, the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill and that single-member limited liability companies and similar disregarded entities that are not subject to income tax are not required to recognize an allocation of consolidated income tax expense in their separate financial statements, but could elect to do so. The guidance is effective for the Company beginning May 1, 2022. Early adoption is permitted. The Company adopted this guidance effective May 1, 2021, and the adoption did not have a material impact on its condensed consolidated financial statements and related disclosures.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Jan. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Geographical Region	The following table presents revenue by geographical region (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2022 2021 2022 2021 North America (1) $ 56,846 $ 29,488 $ 136,995 $ 86,100 Europe, the Middle East and Africa (1) 11,108 17,141 36,116 39,922 Asia Pacific (1) 1,819 1,655 7,331 4,086 Rest of World (1) — 825 — 825 Total revenue $ 69,773 $ 49,109 $ 180,442 $ 130,933 __________________ (1) The United States comprised 81% and 60% of the Company’s revenue for the three months ended January 31, 2022 and 2021, respectively, and 76% and 65% of the Company’s revenue in the nine months ended January 31, 2022 and 2021, respectively. France comprised 8% and 12% of the Company’s revenue for the three months ended January 31, 2022 and 2021, respectively, and 11% and 12% of the Company’s revenue for the nine months ended January 31, 2022 and 2021, respectively. No other country comprised 10% or greater of the Company’s revenue for each of the three and nine months ended January 31, 2022 and 2021.
Schedule of Deferred Revenue Balance and Changes in Deferred Revenues Balances	The following table reflects the deferred revenue balance (in thousands): As of January 31, As of April 30, 2022 2021 Deferred revenue, current $ 58,524 $ 72,263 Deferred revenue, non-current 924 2,964 Total deferred revenue $ 59,448 $ 75,227 Significant changes in the deferred revenue balances during the nine months ended January 31, 2022 and 2021 were as follows (in thousands): Deferred Revenue April 30, 2021 $ 75,227 Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year (68,787) Increases due to invoicing prior to satisfaction of performance obligations 53,008 January 31, 2022 $ 59,448 Deferred Revenue April 30, 2020 $ 60,295 Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year (53,086) Increases due to invoicing prior to satisfaction of performance obligations 55,101 January 31, 2021 $ 62,310

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Jan. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Assets Measured at Fair Value on a Recurring Basis	The following table summarizes the types of assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands): As of January 31, 2022 As of April 30, 2021 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 129,753 $ — $ — $ 129,753 $ 43,401 $ — $ — $ 43,401 Commercial paper — 10,998 — 10,998 — — — — Corporate debt securities — 1,506 — 1,506 — — — — Available-for-sale marketable securities: U.S. treasury securities — — — — — 57,998 — 57,998 Certificates of deposit — 300,381 — 300,381 — 422,978 — 422,978 U.S. government agencies securities — 14,015 — 14,015 — — — — Commercial paper — 308,208 — 308,208 — 494,676 — 494,676 Corporate debt securities — 195,512 — 195,512 — 2,368 — 2,368 Total cash equivalents and available-for-sale marketable securities $ 129,753 $ 830,620 $ — $ 960,373 $ 43,401 $ 978,020 $ — $ 1,021,421

Investments (Tables)

Investments (Tables)	9 Months Ended
	Jan. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-For-Sale Debt Securities and Balance Sheet Classification	The following table summarizes the Company’s cash equivalents and available-for-sale marketable securities (in thousands): As of January 31, 2022 As of April 30, 2021 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash equivalents: Money market funds $ 129,753 $ — $ — $ 129,753 $ 43,401 $ — $ — $ 43,401 Commercial paper 10,998 — — 10,998 — — — — Corporate debt securities 1,506 — — 1,506 — — — — Available-for-sale marketable securities: U.S. treasury securities — — — — 57,993 5 — 57,998 Certificates of deposit 300,377 4 — 300,381 422,952 32 (6) 422,978 U.S. government agencies securities 14,120 — (105) 14,015 — — — — Commercial paper 308,205 3 — 308,208 494,625 64 (13) 494,676 Corporate debt securities 196,210 — (698) 195,512 2,369 — (1) 2,368 Total cash equivalents and available-for-sale marketable securities $ 961,169 $ 7 $ (803) $ 960,373 $ 1,021,340 $ 101 $ (20) $ 1,021,421
Summary of Available-For-Sale Debt Securities by Contractual Maturity	The following table summarizes the Company’s available-for-sale marketable securities by contractual maturity (in thousands): As of January 31, 2022 As of April 30, 2021 Amortized Cost Fair Value Amortized Cost Fair Value Within one year $ 764,589 $ 764,104 $ 977,939 $ 978,020 After one year through five years 54,323 54,012 — — Total $ 818,912 $ 818,116 $ 977,939 $ 978,020
Summary of Available-For-Sale Marketable Securities, Fair Values and Unrealized Losses	The following table summarizes the fair values and unrealized losses of the Company’s available-for-sale marketable securities classified by length of time that the securities have been in a continuous unrealized loss position but were not deemed to be other-than-temporarily impaired, as of January 31, 2022 (in thousands): As of January 31, 2022 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Certificates of deposit $ — $ 12,500 $ — $ — $ — $ 12,500 U.S. government agencies securities — — (105) 14,015 (105) 14,015 Commercial paper — 14,493 — — — 14,493 Corporate debt securities (490) 154,515 (208) 38,297 (698) 192,812 Total $ (490) $ 181,508 $ (313) $ 52,312 $ (803) $ 233,820

Balance Sheet Details (Tables)

Balance Sheet Details (Tables)	9 Months Ended
	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following at January 31, 2022 and April 30, 2021 (in thousands): Useful Life As of January 31, As of April 30, (in months) 2022 2021 Leasehold improvements * $ 8,895 $ 8,658 Computer equipment 36 3,860 2,539 Office furniture and equipment 60 348 339 Capital in progress NA 873 — Property and equipment—gross 13,976 11,536 Less: accumulated depreciation and amortization (8,679) (5,403) Property and equipment—net $ 5,297 $ 6,133 __________________ * Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. NA = Not Applicable
Schedule of Accrued Compensation and Employee Benefits	Accrued compensation and employee benefits consisted of the following at January 31, 2022 and April 30, 2021 (in thousands): As of January 31, As of April 30, 2022 2021 Accrued bonus $ 12,768 $ 12,216 Accrued vacation 3,479 3,935 Accrued payroll taxes and benefits 3,119 3,405 Accrued commission 808 1,863 Accrued salaries 2,414 410 Accrued compensation and employee benefits $ 22,588 $ 21,829
Schedule of Accrued and Other Current Liabilities	Accrued and other current liabilities consisted of the following at January 31, 2022 and April 30, 2021 (in thousands): As of January 31, As of April 30, 2022 2021 Liability for common stock exercised prior to vesting $ 2,449 $ 5,331 Accrued general expenses 5,154 3,588 Operating lease liabilities, current 3,246 3,894 Commissions payable to a related party 18,534 3,413 Other 4,215 2,092 Accrued and other current liabilities $ 33,598 $ 18,318

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Jan. 31, 2022
Share-based Payment Arrangement [Abstract]
Summary of Stock Option Activity	A summary of the Company’s option activity during the nine months ended January 31, 2022 is as follows: Options Outstanding Number of Weighted Weighted Aggregate (in thousands) (in thousands) Balance as of April 30, 2021 38,487 $ 6.39 7.98 $ 2,304,714 Options granted 6,127 46.23 Options exercised (4,174) 4.76 Options cancelled (3,290) 13.71 Balance as of January 31, 2022 37,150 $ 12.47 7.59 $ 515,266 Vested and exercisable as of January 31, 2022 15,195 $ 5.10 6.50 $ 322,749 Vested and expected to vest as of January 31, 2022 (1) 37,629 $ 12.47 7.59 $ 521,914 (1) The number of options vested and expected to vest as of January 31, 2022 includes early exercised, unvested Class A common stock. Refer to Note 8. Stockholders’ Equit y for more information.
Schedule of Valuation Assumptions	The weighted average assumptions underlying the fair value estimation are provided in the following table: As of January 31, 2022 2021 Valuation assumptions: Expected dividend yield — % — % Expected volatility 43.5 % 43.8 % Expected term (years) 6.5 6.3 Risk-free interest rate 1.4 % 0.4 %
Schedule of Restricted Stock Unit Activity	A summary of the Company’s RSU activity during the nine months ended January 31, 2022 is as follows: RSUs Outstanding Number of RSUs Weighted Average (in thousands) Unvested Balance as of April 30, 2021 447 $ 74.52 RSUs granted 7,829 49.60 RSUs vested (54) 66.24 RSUs forfeited (1,297) 58.77 Unvested Balance as of January 31, 2022 6,925 $ 49.36
Summary of Effects of Stock-Based Compensation	The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2022 2021 2022 2021 Cost of subscription $ 2,639 $ 214 $ 5,824 $ 557 Cost of professional services 704 164 1,991 301 Sales and marketing 8,850 2,790 28,540 5,835 Research and development 12,846 846 25,860 1,952 General and administrative 6,322 2,575 15,598 5,625 Total stock-based compensation expense $ 31,361 $ 6,589 $ 77,813 $ 14,270

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Jan. 31, 2022
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended January 31, Nine Months Ended January 31, 2022 2021 2022 2021 Numerator Net loss attributable to common stockholders $ (39,447) $ (16,852) $ (133,645) $ (31,646) Denominator Basic and diluted weighted-average Class A common shares outstanding 101,593 68,648 100,341 43,481 Basic and diluted weighted-average Class A-1 common shares outstanding — 6,667 — 6,667 Basic and diluted weighted-average Class B common shares outstanding 3,500 3,500 3,500 3,500 Basic and diluted net loss per share attributable to common stockholders Basic and diluted net loss per Class A common shares outstanding $ (0.38) $ (0.23) $ (1.29) $ (0.64) Basic and diluted net loss per Class A-1 common shares outstanding $ — $ (0.10) $ — $ (0.52) Basic and diluted net loss per Class B common shares outstanding $ (0.38) $ (0.13) $ (1.29) $ (0.12)
Schedule of Potential Shares of Common Stock Excluded from Computation of Basic and Diluted Net Loss Per Share	The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have had an antidilutive effect were as follows: As of January 31, 2022 2021 Stock options 37,628,988 41,286,541 RSUs 6,925,310 —

Summary of Business and Signi_3

Summary of Business and Significant Accounting Policies (Details) $ / shares in Units, $ in Millions	1 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares	Nov. 30, 2020shares	Jan. 31, 2022shares	Apr. 30, 2021shares
Subsidiary, Sale of Stock [Line Items]
Reverse stock split ratio, common stock		0.1667
Deferred offering costs reclassified into stockholders' equity as a reduction of the IPO proceeds | $	$ 7.2
IPO
Subsidiary, Sale of Stock [Line Items]
Net proceeds received | $	694.6
Private Placement
Subsidiary, Sale of Stock [Line Items]
Net proceeds received | $	$ 150
Class A Common Stock
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized (in shares)		390,000,000	1,000,000,000	1,000,000,000
Class A Common Stock | IPO
Subsidiary, Sale of Stock [Line Items]
Sale of stock, number of shares issued (in shares)	17,825,000
Sale of stock, shares issued, price per share (in dollars per share) | $ / shares	$ 42
Class A Common Stock | Over-Allotment Option
Subsidiary, Sale of Stock [Line Items]
Sale of stock, number of shares issued (in shares)	2,325,000
Class A Common Stock | Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of stock, shares issued, price per share (in dollars per share) | $ / shares	$ 42
Class A Common Stock | Private Placement | Spring Creek Capital LLC
Subsidiary, Sale of Stock [Line Items]
Sale of stock, number of shares issued (in shares)	2,380,952
Class A Common Stock | Private Placement | Microsoft Corporation
Subsidiary, Sale of Stock [Line Items]
Sale of stock, number of shares issued (in shares)	1,190,476
Class A-1 Common Stock
Subsidiary, Sale of Stock [Line Items]
Shares authorized (in shares)		6,666,667
Conversion of stock, converted (in shares)	6,666,665
Conversion ratio	1
Class B Common Stock
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized (in shares)		21,000,000	3,500,000	3,500,000
Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Shares authorized (in shares)		233,107,379
Redeemable Convertible Preferred Stock, Excluding Series A Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Conversion of stock, converted (in shares)	33,628,776
Conversion ratio	1
Series A Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Conversion of stock, converted (in shares)	3,499,992
Conversion ratio	1

Revenue - Disaggregated Revenue

Revenue - Disaggregated Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2022	Jan. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 69,773	$ 49,109	$ 180,442	$ 130,933
North America
Disaggregation of Revenue [Line Items]
Total revenue	56,846	29,488	136,995	86,100
Europe, the Middle East and Africa
Disaggregation of Revenue [Line Items]
Total revenue	11,108	17,141	36,116	39,922
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	1,819	1,655	7,331	4,086
Rest of World
Disaggregation of Revenue [Line Items]
Total revenue	$ 0	$ 825	$ 0	$ 825
United States | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Geographic concentration risk, percentage	81.00%	60.00%	76.00%	65.00%
France | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Geographic concentration risk, percentage	8.00%	12.00%	11.00%	12.00%

Revenue - Deferred Revenue Bala

Revenue - Deferred Revenue Balance (Details) - USD ($) $ in Thousands		Jan. 31, 2022	Apr. 30, 2021	Jan. 31, 2021	Apr. 30, 2020
Revenue from Contract with Customer [Abstract]
Deferred revenue, current	[1]	$ 58,524	$ 72,263
Deferred revenue, non-current		924	2,964
Total deferred revenue		$ 59,448	$ 75,227	$ 62,310	$ 60,295
[1]	Including amounts from a related party of $575 and $7,697 as of January 31, 2022 and April 30, 2021, respectively.

Revenue - Changes in Deferred R

Revenue - Changes in Deferred Revenue (Details) - USD ($) $ in Thousands	9 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Change In Contract With Customer, Liability [Roll Forward]
Beginning Balance	$ 75,227	$ 60,295
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(68,787)	(53,086)
Increases due to invoicing prior to satisfaction of performance obligations	53,008	55,101
Ending Balance	$ 59,448	$ 62,310

Revenue - Remaining Performance

Revenue - Remaining Performance Obligation (Details) - USD ($) $ in Millions	Jan. 31, 2022	Apr. 30, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations, amount	$ 469.3	$ 293.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations, amount		$ 145.2
Revenue expected to be recognized from remaining performance obligations, period
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations, amount	$ 171.6
Revenue expected to be recognized from remaining performance obligations, period

Revenue - Customer Concentratio

Revenue - Customer Concentration and Accounts Receivable (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2022	Jan. 31, 2021	Apr. 30, 2021
Disaggregation of Revenue [Line Items]
Unbilled receivables	$ 5.1		$ 5.1		$ 3.8
Customer Concentration Risk | Revenue | Customer One
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage	36.00%	16.00%	30.00%	16.00%
Customer Concentration Risk | Revenue | Customer Two
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage	10.00%	12.00%	10.00%	12.00%
Customer Concentration Risk | Accounts Receivable | Customer One
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage			21.00%		18.00%
Customer Concentration Risk | Accounts Receivable | Customer Two
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage			19.00%		14.00%
Customer Concentration Risk | Accounts Receivable | Customer Three
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage			14.00%		14.00%
Customer Concentration Risk | Accounts Receivable | Customer Four
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage			12.00%		11.00%

Fair Value Measurements - Asset

Fair Value Measurements - Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Jan. 31, 2022	Apr. 30, 2021
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	$ 960,373	$ 1,021,421
Corporate debt securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	195,512	2,368
U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	57,998
Certificates of deposit
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	300,381	422,978
U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	14,015	0
Commercial paper
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	308,208	494,676
Fair Value, Recurring
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	960,373	1,021,421
Fair Value, Recurring | Money market funds
Cash equivalents:
Cash equivalents, fair value	129,753	43,401
Fair Value, Recurring | Corporate debt securities
Cash equivalents:
Cash equivalents, fair value	1,506	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	195,512	2,368
Fair Value, Recurring | U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	57,998
Fair Value, Recurring | Certificates of deposit
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	300,381	422,978
Fair Value, Recurring | U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	14,015	0
Fair Value, Recurring | Commercial paper
Cash equivalents:
Cash equivalents, fair value	10,998	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	308,208	494,676
Fair Value, Recurring | Level 1
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	129,753	43,401
Fair Value, Recurring | Level 1 | Money market funds
Cash equivalents:
Cash equivalents, fair value	129,753	43,401
Fair Value, Recurring | Level 1 | Corporate debt securities
Cash equivalents:
Cash equivalents, fair value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 1 | U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 1 | Certificates of deposit
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 1 | U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 1 | Commercial paper
Cash equivalents:
Cash equivalents, fair value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 2
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	830,620	978,020
Fair Value, Recurring | Level 2 | Money market funds
Cash equivalents:
Cash equivalents, fair value	0	0
Fair Value, Recurring | Level 2 | Corporate debt securities
Cash equivalents:
Cash equivalents, fair value	1,506	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	195,512	2,368
Fair Value, Recurring | Level 2 | U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	57,998
Fair Value, Recurring | Level 2 | Certificates of deposit
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	300,381	422,978
Fair Value, Recurring | Level 2 | U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	14,015	0
Fair Value, Recurring | Level 2 | Commercial paper
Cash equivalents:
Cash equivalents, fair value	10,998	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	308,208	494,676
Fair Value, Recurring | Level 3
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	0	0
Fair Value, Recurring | Level 3 | Money market funds
Cash equivalents:
Cash equivalents, fair value	0	0
Fair Value, Recurring | Level 3 | Corporate debt securities
Cash equivalents:
Cash equivalents, fair value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 3 | U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 3 | Certificates of deposit
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 3 | U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 3 | Commercial paper
Cash equivalents:
Cash equivalents, fair value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	$ 0	$ 0

Investments - Available-for-Sal

Investments - Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	Jan. 31, 2022	Apr. 30, 2021	Jan. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Cash equivalents	$ 204,531	$ 115,355	$ 960,122
Gross Unrealized Gains	7	101
Gross Unrealized Losses	(803)	(20)
Cash, cash equivalents and available-for-sale debt securities, amortized cost	961,169	1,021,340
Total cash equivalents and available-for-sale marketable securities	960,373	1,021,421
Money market funds
Debt Securities, Available-for-sale [Line Items]
Cash equivalents	129,753	43,401
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Cash equivalents	10,998	0
Amortized Cost	308,205	494,625
Gross Unrealized Gains	3	64
Gross Unrealized Losses	0	(13)
Estimated Fair Value	308,208	494,676
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Cash equivalents	1,506	0
Amortized Cost	196,210	2,369
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(698)	(1)
Estimated Fair Value	195,512	2,368
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	0	57,993
Gross Unrealized Gains	0	5
Gross Unrealized Losses	0	0
Estimated Fair Value	0	57,998
Certificates of deposit
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	300,377	422,952
Gross Unrealized Gains	4	32
Gross Unrealized Losses	0	(6)
Estimated Fair Value	300,381	422,978
U.S. government agencies securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	14,120	0
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(105)	0
Estimated Fair Value	$ 14,015	$ 0

Investments - Available-for Sal

Investments - Available-for Sale Debt Securities by Contractual Maturity (Details) - Debt Securities, Available-For-Sale, Excluding Money Market Accounts - USD ($) $ in Thousands	Jan. 31, 2022	Apr. 30, 2021
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
AFS Debt Maturities, Within one year, Amortized Cost	$ 764,589	$ 977,939
AFS Debt Maturities, After one year through five years, Amortized Cost	54,323	0
Amortized Cost	818,912	977,939
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
AFS Debt Maturities, Within one year, Fair Value	764,104	978,020
AFS Debt Maturities, After one year through five years, Fair Value	54,012	0
AFS Debt Maturities, Total Fair Value	$ 818,116	$ 978,020

Investments - Available-for-S_2

Investments - Available-for-Sale Marketable Securities, Fair Value and Unrealized Losses Continuous Unrealized Loss Position (Details) $ in Thousands	Jan. 31, 2022USD ($)
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	$ (490)
AFS, Less Than 12 Months, Fair Value	181,508
AFS, 12 Months or Greater, Unrealized Losses	(313)
AFS, 12 Months or Greater, Fair Value	52,312
AFS, Total Unrealized Losses	(803)
AFS, Total Fair Value	233,820
Certificates of deposit
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	0
AFS, Less Than 12 Months, Fair Value	12,500
AFS, 12 Months or Greater, Unrealized Losses	0
AFS, 12 Months or Greater, Fair Value	0
AFS, Total Unrealized Losses	0
AFS, Total Fair Value	12,500
U.S. government agencies securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	0
AFS, Less Than 12 Months, Fair Value	0
AFS, 12 Months or Greater, Unrealized Losses	(105)
AFS, 12 Months or Greater, Fair Value	14,015
AFS, Total Unrealized Losses	(105)
AFS, Total Fair Value	14,015
Commercial paper
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	0
AFS, Less Than 12 Months, Fair Value	14,493
AFS, 12 Months or Greater, Unrealized Losses	0
AFS, 12 Months or Greater, Fair Value	0
AFS, Total Unrealized Losses	0
AFS, Total Fair Value	14,493
Corporate debt securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	(490)
AFS, Less Than 12 Months, Fair Value	154,515
AFS, 12 Months or Greater, Unrealized Losses	(208)
AFS, 12 Months or Greater, Fair Value	38,297
AFS, Total Unrealized Losses	(698)
AFS, Total Fair Value	$ 192,812

Investments - Narrative (Detail

Investments - Narrative (Details)	9 Months Ended
	Jan. 31, 2022USD ($)investment	Apr. 30, 2021investment
Investments, Debt and Equity Securities [Abstract]
Number of investment positions in unrealized loss position | investment	185	8
Other-than-temporary impairment loss | $	$ 0

Balance Sheet Details - Propert

Balance Sheet Details - Property and Equipment (Details) - USD ($) $ in Thousands	9 Months Ended
	Jan. 31, 2022	Apr. 30, 2021
Property, Plant and Equipment [Line Items]
Property and equipment—gross	$ 13,976	$ 11,536
Less: accumulated depreciation and amortization	(8,679)	(5,403)
Property and equipment—net	5,297	6,133
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment—gross	$ 8,895	8,658
Computer equipment
Property, Plant and Equipment [Line Items]
Useful Life	36 months
Property and equipment—gross	$ 3,860	2,539
Office furniture and equipment
Property, Plant and Equipment [Line Items]
Useful Life	60 months
Property and equipment—gross	$ 348	339
Capital in progress
Property, Plant and Equipment [Line Items]
Property and equipment—gross	$ 873	$ 0

Balance Sheet Details - Narrati

Balance Sheet Details - Narrative (Details) - USD ($) $ in Millions	Aug. 18, 2020	May 01, 2020	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2022	Jan. 31, 2021
Short-term Debt [Line Items]
Depreciation expense			$ 1.1	$ 1	$ 3.3	$ 3
Paycheck Protection Program, CARES Act
Short-term Debt [Line Items]
Loan proceeds, promissory note		$ 6.3
Repayment of loan, promissory note, interest	$ 0.1
Repayment of loan, promissory note	$ 6.4

Balance Sheet Details - Accrued

Balance Sheet Details - Accrued Compensation and Employee Benefits (Details) - USD ($) $ in Thousands	Jan. 31, 2022	Apr. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued bonus	$ 12,768	$ 12,216
Accrued vacation	3,479	3,935
Accrued payroll taxes and benefits	3,119	3,405
Accrued commission	808	1,863
Accrued salaries	2,414	410
Accrued compensation and employee benefits	$ 22,588	$ 21,829

Balance Sheet Details - Accru_2

Balance Sheet Details - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands		Jan. 31, 2022	Apr. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liability for common stock exercised prior to vesting		$ 2,449	$ 5,331
Accrued general expenses		5,154	3,588
Operating lease liabilities, current		3,246	3,894
Commissions payable to a related party		18,534	3,413
Other		4,215	2,092
Accrued and other current liabilities	[1]	$ 33,598	$ 18,318
[1]	Including amounts from a related party of $18,534 and $3,413 as of January 31, 2022 and April 30, 2021, respectively.

Commitments and Contingencies (

Commitments and Contingencies (Details)	Dec. 06, 2021USD ($)	Aug. 10, 2021USD ($)	Feb. 29, 2020	Nov. 30, 2019USD ($)	Jan. 31, 2022USD ($)ft²phase	Jan. 31, 2021USD ($)	Jan. 31, 2022USD ($)ft²phase	Jan. 31, 2021USD ($)	Apr. 30, 2021USD ($)
Long-term Purchase Commitment [Line Items]
Purchase commitment, incurred cost					$ 3,800,000	$ 3,500,000	$ 10,400,000	$ 9,600,000
Lease, area under lease | ft²					283,015		283,015
Lease, total undiscounted base rent payments over term of lease					$ 103,100,000		$ 103,100,000
Lease, term of rent abatement per phase, following rent commencement date					6 months
Lease, monthly base rent					$ 500,000		500,000
Lessee, tenant improvement allowance					$ 44,200,000		$ 44,200,000
Lease, term					126 months		126 months
Lease, period after date phase one delivered					9 months		9 months
Lease, number of phases | phase					2		2
Operating lease, liability					$ 26,500,000		$ 26,500,000
Operating lease, right-of-use assets					26,500,000		26,500,000
Blattman et al. v. Siebel et al. | Pending Litigation
Long-term Purchase Commitment [Line Items]
Recommended amount to be awarded from other party		$ 9,700,000
Requested by plaintiff, amount to be awarded from other party		$ 8,300,000
Blattman et al. v. Siebel et al. | Settled Litigation
Long-term Purchase Commitment [Line Items]
Amount awarded from other party	$ 9,400,000
Blattman et al. v. Siebel et al. | Settled Litigation | Other Income (Expense)
Long-term Purchase Commitment [Line Items]
Amount awarded from other party					9,400,000		9,400,000
Landlord | Letter of Credit | Line of Credit
Long-term Purchase Commitment [Line Items]
Letter of credit outstanding					12,600,000		12,600,000
Maximum
Long-term Purchase Commitment [Line Items]
Lease, monthly base rent					1,000,000		1,000,000
C3.ai DTI Grants Program
Long-term Purchase Commitment [Line Items]
Grants, payment period			5 years
Grants, potential remaining contributions					$ 34,500,000		$ 34,500,000		$ 43,100,000
Web-Hosting Services, November 2019-November 2022
Long-term Purchase Commitment [Line Items]
Purchase commitment				$ 30,000,000
Purchase commitment, term				3 years
Web-Hosting Services, November 2020
Long-term Purchase Commitment [Line Items]
Purchase commitment				$ 10,000,000
Web-Hosting Services, November 2021
Long-term Purchase Commitment [Line Items]
Purchase commitment				10,000,000
Web-Hosting Services, November 2022
Long-term Purchase Commitment [Line Items]
Purchase commitment				$ 10,000,000

Redeemable Convertible Prefer_2

Redeemable Convertible Preferred Stock and Redeemable Convertible A-1 Common Stock (Details) $ in Thousands	1 Months Ended	3 Months Ended	9 Months Ended
	Dec. 31, 2020USD ($)shares	Jan. 31, 2021USD ($)shares	Jan. 31, 2021USD ($)shares	Jan. 31, 2022shares	Oct. 31, 2021shares	Apr. 30, 2021shares	Oct. 31, 2020shares	Apr. 30, 2020shares
Redeemable Convertible Preferred Stock, Excluding Series A Preferred Stock
Temporary Equity [Line Items]
Conversion of stock, converted (in shares)	33,628,776
Conversion ratio	1
Series A Preferred Stock
Temporary Equity [Line Items]
Conversion of stock, converted (in shares)	3,499,992
Conversion ratio	1
Redeemable Convertible Preferred Stock
Temporary Equity [Line Items]
Carrying value reclassified into stockholders' equity | $	$ 399,800	$ 399,753	$ 399,753
Shares issued (in shares)				0
Shares outstanding (in shares)		0	0	0	0	0	37,129,000	37,129,000
Redeemable Convertible A-1 Common Stock
Temporary Equity [Line Items]
Conversion of stock, converted (in shares)	6,666,665
Conversion ratio	1
Carrying value reclassified into stockholders' equity | $	$ 18,800	$ 18,800	$ 18,800
Shares issued (in shares)				0
Shares outstanding (in shares)		0	0	0	0	0	6,667,000	6,667,000

Stockholders' Equity (Details)

Stockholders' Equity (Details)	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2021USD ($)	Jan. 31, 2022USD ($)vote$ / sharesshares	Jan. 31, 2021USD ($)	Jan. 31, 2022USD ($)vote$ / sharesshares	Jan. 31, 2021USD ($)	Apr. 30, 2021$ / sharesshares	Nov. 30, 2020shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized (in shares)		200,000,000		200,000,000
Preferred stock, par value (in dollars per share) | $ / shares		$ 0.001		$ 0.001
Preferred stock, shares issued (in shares)		0		0
Preferred stock, shares outstanding (in shares)		0		0
Automatic conversion period, following the death or incapacity of Mr. Siebel				6 months
Automatic conversion period, following the date Mr. Siebel no longer providing services				6 months
Automatic conversion, anniversary period, if circumstances met				20 years
Net proceeds common stock exercised prior to vesting | $		$ 0	$ 4,500,000	$ 0	$ 6,000,000
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares subject to repurchase right (in shares)				479,327		1,091,306
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)		1,000,000,000		1,000,000,000		1,000,000,000	390,000,000
Voting rights, number of votes for each share | vote		1		1
Common stock, par value (in dollars per share) | $ / shares		$ 0.001		$ 0.001		$ 0.001
Stock repurchase program, authorized amount (up to) | $	$ 100,000,000
Stock repurchase program, repurchase period	18 months
Stock repurchase program, shares repurchased (in shares)		0		0
Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)		3,500,000		3,500,000		3,500,000	21,000,000
Voting rights, number of votes for each share | vote		50		50
Common stock, par value (in dollars per share) | $ / shares		$ 0.001		$ 0.001		$ 0.001

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($)	1 Months Ended		3 Months Ended	7 Months Ended	9 Months Ended
	Sep. 30, 2020	Jan. 31, 2018	Apr. 30, 2021	Dec. 10, 2020	Jan. 31, 2022	May 01, 2021	Nov. 27, 2020
Chief Executive Officer (CEO)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Notes receivable		$ 24,500,000
Proceeds from notes receivable payment	$ 26,000,000
Chief Executive Officer (CEO) | Notes Receivable
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Interest income	$ 0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost					$ 166,300,000
Unrecognized compensation cost, weighted-average recognition period					3 years 4 months 24 days
Vesting period					5 years
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, weighted-average recognition period					3 years 10 months 24 days
Granted, non-option (in shares)				0	7,829,000
Vesting period			5 years
Unrecognized stock-based compensation expense					$ 296,200,000
2020 Incentive Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period					10 years
2020 Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of employee earnings participation (up to)							15.00%
Common Class A and Common Class B | 2020 Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Automatic increase to shares reserved for future issuance, percent of total shares outstanding as of April 30, 2021						5.00%
Common Class A and Common Class B | 2020 Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Automatic increase to shares reserved for future issuance, percent of total shares outstanding as of April 30, 2021						1.00%
Class A Common Stock | 2020 Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)							3,000,000
Series F Preferred Stock | Chief Executive Officer (CEO)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock issued during period (in shares)		1,251,921

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Jan. 31, 2022USD ($)$ / sharesshares	Apr. 30, 2021USD ($)$ / sharesshares
Number of Stock Options Outstanding
Balance at beginning of period (in shares) | shares	38,487
Options granted (in shares) | shares	6,127
Options exercised (in shares) | shares	(4,174)
Options cancelled (in shares) | shares	(3,290)
Balance at end of period (in shares) | shares	37,150	38,487
Vested and exercisable at end of period (in shares) | shares	15,195
Vested and expected to vest at end of period (in shares) | shares	37,629
Weighted Average Exercise Price
Balance at beginning of period (in dollars per share) | $ / shares	$ 6.39
Options granted (in dollars per share) | $ / shares	46.23
Options exercised (in dollars per share) | $ / shares	4.76
Options cancelled (in dollars per share) | $ / shares	13.71
Balance at end of period (in dollars per share) | $ / shares	12.47	$ 6.39
Vested and exercisable at end of period (in dollars per share) | $ / shares	5.10
Vested and expected to vest at end of period (in dollars per share) | $ / shares	$ 12.47
Weighted Average Remaining Contractual Life (years)
Balance at beginning of period	7 years 7 months 2 days	7 years 11 months 23 days
Balance at end of period	7 years 7 months 2 days	7 years 11 months 23 days
Vested and exercisable at end of period	6 years 6 months
Vested and expected to vest at end of period	7 years 7 months 2 days
Aggregate Intrinsic Value
Balance at beginning of period | $	$ 515,266	$ 2,304,714
Balance at end of period | $	515,266	$ 2,304,714
Vested and exercisable at end of period | $	322,749
Vested and expected to vest at end of period | $	$ 521,914

Stock-Based Compensation - Valu

Stock-Based Compensation - Valuation Assumptions (Details)	9 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Valuation assumptions:
Expected dividend yield	0.00%	0.00%
Expected volatility	43.50%	43.80%
Expected term (years)	6 years 6 months	6 years 3 months 18 days
Risk-free interest rate	1.40%	0.40%

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Unit Activity (Details) - RSUs - $ / shares	7 Months Ended	9 Months Ended
	Dec. 10, 2020	Jan. 31, 2022
Number of RSUs
Unvested Balance at beginning of period (in shares)		447,000
RSUs granted (in shares)	0	7,829,000
RSUs vested (in shares)		(54,000)
RSUs forfeited (in shares)		(1,297,000)
Unvested Balance at end of period (in shares)		6,925,000
Weighted Average Grant Date Fair Value Per Share
Unvested Balance at beginning of period (in dollars per share)		$ 74.52
RSUs granted (in dollars per share)		49.60
RSUs vested (in dollars per share)		66.24
RSUs forfeited (in dollars per share)		58.77
Unvested Balance at end of period (in dollars per share)		$ 49.36

Stock-Based Compensation - St_2

Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 31,361	$ 6,589	$ 77,813	$ 14,270
Cost of revenue | Subscription
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	2,639	214	5,824	557
Cost of revenue | Professional services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	704	164	1,991	301
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	8,850	2,790	28,540	5,835
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	12,846	846	25,860	1,952
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 6,322	$ 2,575	$ 15,598	$ 5,625

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2022	Jan. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense	$ 0.2	$ 0.2	$ 0.6	$ 0.5

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2022	Jan. 31, 2021
Numerator
Net loss attributable to common stockholders	$ (39,447)	$ (16,852)	$ (133,645)	$ (31,646)
Class A Common Stock
Denominator
Basic weighted-average Class A common shares outstanding (in shares)	101,593,000	68,648,000	100,341,000	43,481,000
Diluted weighted-average Class A common shares outstanding (in shares)	101,593,000	68,648,000	100,341,000	43,481,000
Basic and diluted net loss per share attributable to common stockholders
Basic net loss per Class A common shares outstanding (in dollars per share)	$ (0.38)	$ (0.23)	$ (1.29)	$ (0.64)
Diluted net loss per Class A common shares outstanding (in dollars per share)	$ (0.38)	$ (0.23)	$ (1.29)	$ (0.64)
Class A-1 Common Stock
Denominator
Basic weighted-average Class A common shares outstanding (in shares)	0	6,667,000	0	6,667,000
Diluted weighted-average Class A common shares outstanding (in shares)	0	6,667,000	0	6,667,000
Basic and diluted net loss per share attributable to common stockholders
Basic net loss per Class A common shares outstanding (in dollars per share)	$ 0	$ (0.10)	$ 0	$ (0.52)
Diluted net loss per Class A common shares outstanding (in dollars per share)	$ 0	$ (0.10)	$ 0	$ (0.52)
Class B Common Stock
Denominator
Basic weighted-average Class A common shares outstanding (in shares)	3,500,000	3,500,000	3,500,000	3,500,000
Diluted weighted-average Class A common shares outstanding (in shares)	3,500,000	3,500,000	3,500,000	3,500,000
Basic and diluted net loss per share attributable to common stockholders
Basic net loss per Class A common shares outstanding (in dollars per share)	$ (0.38)	$ (0.13)	$ (1.29)	$ (0.12)
Diluted net loss per Class A common shares outstanding (in dollars per share)	$ (0.38)	$ (0.13)	$ (1.29)	$ (0.12)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Potential Shares Excluded From Computation of Diluted Net Loss Per Share (Details) - shares	9 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive shares excluded from computation of net loss per share (in shares)	37,628,988	41,286,541
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive shares excluded from computation of net loss per share (in shares)	6,925,310	0

Related Party Transactions (Det

Related Party Transactions (Details) $ in Thousands		1 Months Ended					3 Months Ended		9 Months Ended
		Oct. 31, 2021	Sep. 30, 2020USD ($)	Jun. 30, 2020	Jun. 30, 2019USD ($)	Jan. 31, 2018USD ($)renewalPeriodshares	Jan. 31, 2022USD ($)	Jan. 31, 2021USD ($)	Jan. 31, 2022USD ($)	Jan. 31, 2021USD ($)	Apr. 30, 2021USD ($)	Apr. 30, 2020USD ($)
Related Party Transaction [Line Items]
Deferred revenue							$ 59,448	$ 62,310	$ 59,448	$ 62,310	$ 75,227	$ 60,295
Accounts receivable, net, from related party							15,727		15,727		15,180
Deferred revenue, current	[1]						58,524		58,524		72,263
Sales and marketing expenses	[2]						43,146	28,450	126,134	64,898
Accounts payable, from related party							2,415		2,415		56
Commissions payable to a related party							18,534		18,534		3,413
Software Subscription Agreement | Baker Hughes Company
Related Party Transaction [Line Items]
Revenue commitment, fiscal year 2020					$ 46,700
Revenue commitment, fiscal year 2021					53,300
Revenue commitment, fiscal year 2022					75,000
Revenue commitment, fiscal year 2023					125,000		85,000		85,000
Revenue commitment, fiscal year 2024					$ 150,000		110,000		110,000
Revenue commitment, fiscal year 2025							125,000		125,000
Chief Executive Officer (CEO)
Related Party Transaction [Line Items]
Notes receivable						$ 24,500
Notes receivable, term						5 years
Notes receivable, number of renewal periods | renewalPeriod						4
Notes receivable, renewal period						1 year
Interest rate						2.18%
Proceeds from notes receivable payment			$ 26,000
Baker Hughes Company | Software Subscription Agreement
Related Party Transaction [Line Items]
Revenue commitment, term		6 years		5 years	3 years
Sales commissions, recognized as deferred costs							$ 16,000		$ 16,000		$ 8,300
Deferred costs, sales commissions, amortization period							5 years		5 years		3 years
Related party revenue									$ 70,900
Deferred revenue							$ 2,300		2,300		$ 8,500
Commitments from non-cancellable contracts							234,900		234,900		95,500
Accounts receivable, net, from related party							15,700		15,700		15,200
Deferred revenue, current							600		600		7,700
Costs of subscription revenue							200	0	400	0
Sales and marketing expenses							2,400	0	2,600	0
Accounts payable, from related party							2,400		2,400		100
Deferred costs, sales commissions, prepaid expense and other current assets							5,000		5,000		1,700
Deferred costs, sales commissions, other assets, non-current							17,400		17,400		6,600
Deferred costs, sales commissions, amortization							1,200		2,000
Sales commissions paid									3,400
Commissions payable to a related party							18,500		18,500		3,400
Due to related parties, noncurrent							2,400		2,400		$ 4,900
Baker Hughes Company | Subscription | Software Subscription Agreement
Related Party Transaction [Line Items]
Related party revenue							19,700	8,000	40,000	21,600
Baker Hughes Company | Professional services | Software Subscription Agreement
Related Party Transaction [Line Items]
Related party revenue							$ 4,900	$ 0	$ 12,900	$ 0
Series F Preferred Stock | Chief Executive Officer (CEO)
Related Party Transaction [Line Items]
Stock issued during period (in shares) | shares						1,251,921
[1]	Including amounts from a related party of $575 and $7,697 as of January 31, 2022 and April 30, 2021, respectively.
[2]	Including related party sales and marketing expense of $2,398 and nil for the three months ended January 31, 2022 and 2021, respectively, and $2,590 and nil for the nine months ended January 31, 2022 and 2021, respectively.